Notice: This company has been marked as potentially delisted and may not be actively trading. Ocuphire Pharma (OCUP) Institutional Ownership Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestTrends Institutional Ownership Changes (13F Filings) for Ocuphire Pharma (NASDAQ:OCUP)CurrentInstitutional OwnershipPercentage14.97%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$477.27KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$1.26M Get OCUP Insider Trade Alerts Want to know when executives and insiders are buying or selling Ocuphire Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OCUP Institutional Buying and Selling by Quarter Ad DTIForced out of retirement by these trades You know, I never really intended to get in front of a camera and tell folks about a new market paradigm that I discovered. Even though I have a bright and shiny “resume,” I thought I’d left investing behind forever. And I was more than happy to be a stay-at-home dad… But then I discovered Gamma Pockets… and everything changedMake sure to check out Gamma Pockets HERE while it’s still widely available Ocuphire Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/12/2024 Richmond Brothers Inc.191,304$293K0.6%-15.9%0.738% 8/9/2024 Renaissance Technologies LLC41,700$64K0.0%-69.2%0.161% 8/8/2024 Rice Hall James & Associates LLC223,589$342K0.0%-23.4%0.863% 5/20/2024 Virtu Financial LLC17,752$36K0.0%N/A0.068% 5/10/2024 Vanguard Group Inc.992,200$1.99M0.0%+6.9%3.874% 5/10/2024 Richmond Brothers Inc.227,461$457K0.8%-10.0%0.888% Get the Latest News and Ratings for OCUP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ocuphire Pharma and its competitors with MarketBeat's FREE daily newsletter. 5/7/2024 Empowered Funds LLC36,605$74K0.0%N/A0.143% 4/23/2024 Rice Hall James & Associates LLC291,985$587K0.0%-48.9%1.177% 2/8/2024 Richmond Brothers Inc.252,769$761K1.3%-31.3%1.117% 2/5/2024 Victory Capital Management Inc.46,916$141K0.0%N/A0.207% 2/5/2024 Kestra Private Wealth Services LLC42,341$127K0.0%+323.4%0.187% 11/13/2023 Acadian Asset Management LLC49,563$165K0.0%+75.5%0.236% 11/3/2023 Richmond Brothers Inc.368,003$1.23M2.3%+7.6%1.752% 11/2/2023 Rice Hall James & Associates LLC828,628$2.78M0.2%-2.4%3.944% 10/24/2023Stratos Wealth Partners LTD.23,925$80K0.0%-51.4%0.114% 10/12/2023 Legato Capital Management LLC10,098$34K0.0%-38.6%0.048% 9/8/2023Tucker Asset Management LLC29,106$126K0.0%N/A0.139% 8/11/2023 O Shaughnessy Asset Management LLC11,525$50K0.0%N/A0.055% 8/10/2023 Private Advisor Group LLC10,200$44K0.0%-49.0%0.049% 8/7/2023 Acadian Asset Management LLC28,245$122K0.0%N/A0.135% 8/2/2023 MAI Capital Management485,048$2.11M0.0%-1.9%2.315% 7/24/2023 Rice Hall James & Associates LLC849,286$3.69M0.2%+5.0%4.054% 7/18/2023Stratos Wealth Partners LTD.49,195$214K0.0%N/A0.235% 7/13/2023 Thompson Davis & CO. Inc.18,188$79K0.1%N/A0.087% 7/10/2023 Trust Co. of Toledo NA OH32,399$141K0.0%+24.6%0.155% 5/12/2023 Rice Hall James & Associates LLC809,117$3.03M0.2%+0.4%3.863% 5/10/2023 Richmond Brothers Inc.340,526$1.28M2.2%+3.5%1.625% 5/10/2023 MAI Capital Management494,690$1.86M0.0%+12.4%2.361% 4/4/2023 Trust Co. of Toledo NA OH26,000$98K0.0%N/A0.124% 2/9/2023 MAI Capital Management440,071$1.55M0.0%+23.3%2.115% 2/8/2023 Lincoln National Corp11,600$41K0.0%N/A0.056% 2/8/2023 Richmond Brothers Inc.328,970$1.16M1.6%+2.7%1.581% 2/1/2023 Legato Capital Management LLC16,456$58K0.0%N/A0.079% 1/27/2023 Rice Hall James & Associates LLC806,067$2.85M0.2%+49.2%3.874% 1/18/2023 Private Advisor Group LLC20,000$71K0.0%N/A0.096% 11/8/2022 Bedel Financial Consulting Inc.15,000$31K0.0%N/A0.073% 11/2/2022 Richmond Brothers Inc.320,332$641K0.7%+3.0%1.557% 11/1/2022 Rice Hall James & Associates LLC540,348$1.09M0.1%+65.0%2.626% 8/12/2022 Richmond Brothers Inc.311,120$597K0.6%+149.8%1.607% 8/11/2022 Warberg Asset Management LLC24,200$46K0.0%N/A0.125% Why I'm telling friends to avoid gold stocks (Ad)Back in November, gold made a tiny move of 1.6%. But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week. It happened again in March. Gold nudged up 1.2%. This time? A 104% overnight gain. And in June? A 1% gold move turned into a 74% gain in two weeks. Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now. There's a more lucrative way to play the gold market as we enter a new breakout period. It's all about catching what I call "Acceleration Cycles."And if you’d like to get your hands on this, here you go, the complete breakdown.8/8/2022 Rice Hall James & Associates LLC327,494$629K0.0%+125.8%1.691% 7/19/2022Eidelman Virant Capital25,000$48K0.0%N/A0.129% 5/9/2022 Powell Investment Advisors LLC13,500$44K0.0%N/A0.070% 5/5/2022 MCF Advisors LLC9,499$31K0.0%N/A0.049% 5/5/2022 Richmond Brothers Inc.124,544$403K0.3%+67.4%0.647% 4/18/2022 Spire Wealth Management9,002$29K0.0%N/A0.047% 2/14/2022 Rice Hall James & Associates LLC132,433$494K0.0%N/A0.766% 2/14/2022 Diametric Capital LP89,442$334K0.3%N/A0.517% 2/10/2022 Richmond Brothers Inc.74,420$277K0.2%N/A0.430% 2/4/2022Frontier Wealth Management LLC18,000$67K0.0%-28.0%0.104% 8/25/2021 Marshall Wace LLP329,131$1.74M0.0%N/A1.948% 8/17/2021 Man Group plc14,900$79K0.0%N/A0.119% 8/16/2021 Squarepoint Ops LLC19,395$102K0.0%+87.1%0.154% 8/16/2021 Occudo Quantitative Strategies LP23,445$124K0.0%N/A0.187% 8/16/2021 State Street Corp54,573$288K0.0%N/A0.434% 8/16/2021 Goldman Sachs Group Inc.37,315$197K0.0%N/A0.297% 8/16/2021 Marshall Wace LLP329,131$1.74M0.0%N/A2.620% 8/13/2021 Renaissance Technologies LLC35,529$188K0.0%-68.7%0.283% 8/13/2021 Geode Capital Management LLC25,594$135K0.0%+126.5%0.204% 8/13/2021 Vanguard Group Inc.37,146$196K0.0%+170.7%0.296% 8/11/2021 Susquehanna International Group LLP59,172$312K0.0%N/A0.471% 8/11/2021Susquehanna Fundamental Investments LLC16,441$87K0.0%N/A0.131% 5/25/2021 Regency Capital Management Inc. DE17,000$99K0.1%N/A0.135% 5/19/2021 Squarepoint Ops LLC10,365$60K0.0%-47.0%0.082% 5/18/2021 Millennium Management LLC12,692$74K0.0%N/A0.101% 5/17/2021 Ikarian Capital LLC119,551$693K0.0%N/A0.952% 5/13/2021 Renaissance Technologies LLC113,620$660K0.0%+53.9%0.904% 5/12/2021 Geode Capital Management LLC11,300$65K0.0%N/A0.090% 5/12/2021 Pura Vida Investments LLC57,536$334K0.0%N/A0.458% 5/6/2021 Altium Capital Management LP397,036$2.31M0.6%-80.8%3.379% 4/30/2021 Norris Perne & French LLP MI78,909$458K0.0%N/A0.722% 2/16/2021 Squarepoint Ops LLC19,572$127K0.0%N/A0.180% 2/10/2021 Renaissance Technologies LLC73,820$479K0.0%N/A6.585% 1/28/2021 Comerica Bank30,000$322K0.0%N/A2.676% (Data available from 1/1/2016 forward) OCUP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OCUP shares? During the previous two years, 18 institutional investors and hedge funds held shares of Ocuphire Pharma. The most heavily invested institutionals were MAI Capital Management ($2.11M), Vanguard Group Inc. ($1.99M), Rice Hall James & Associates LLC ($342K), Richmond Brothers Inc. ($293K), Acadian Asset Management LLC ($165K), Victory Capital Management Inc. ($141K), and Trust Co. of Toledo NA OH ($141K).Learn more on OCUP's institutional investors. What percentage of Ocuphire Pharma stock is owned by institutional investors? 14.97% of Ocuphire Pharma stock is owned by institutional investors. Learn more on OCUP's institutional investor holdings. Which institutional investors have been buying Ocuphire Pharma stock? Of the 17 institutional investors that purchased Ocuphire Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Rice Hall James & Associates LLC ($308.94K), MAI Capital Management ($137.74K), Vanguard Group Inc. ($64.40K), Acadian Asset Management LLC ($49.56K), Stratos Wealth Partners LTD. ($49.20K), Victory Capital Management Inc. ($46.92K), and Richmond Brothers Inc. ($46.34K). How much institutional buying is happening at Ocuphire Pharma? Institutional investors have bought a total of 929,063 shares in the last 24 months. This purchase volume represents approximately $3.22M in transactions. Which Ocuphire Pharma major shareholders have been selling company stock? The following institutional investors have sold Ocuphire Pharma stock in the last 24 months: Rice Hall James & Associates LLC ($368.85K), Richmond Brothers Inc. ($176.70K), Renaissance Technologies LLC ($93.60K), Stratos Wealth Partners LTD. ($25.27K), Private Advisor Group LLC ($9.80K), MAI Capital Management ($9.64K), and Legato Capital Management LLC ($6.36K). How much institutional selling is happening at Ocuphire Pharma? Institutional investors have sold a total of 690,215 shares in the last 24 months. This volume of shares sold represents approximately $1.52M in transactions. Related Companies Leap Therapeutics Major Shareholders Veru Major Shareholders Regulus Therapeutics Major Shareholders Journey Medical Major Shareholders Alto Neuroscience Major Shareholders Immunic Major Shareholders Skye Bioscience Major Shareholders MediciNova Major Shareholders Context Therapeutics Major Shareholders Avalo Therapeutics Major Shareholders This page (NASDAQ:OCUP) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredI was wrong. Dead wrong. Something is stirring deep in Silicon Valley. My team and I have been watching the tech markets closely. ...Porter & Company | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredBuy this Stock before Trump Takes Office!To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowerin...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ocuphire Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ocuphire Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
